Dr. Eric Winer moderated a panel at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium focusing on medical economics and the cost of cancer care. How do we begin to address these issues? Dr. Winer is Chief of Women’s Cancers at Dana-Farber Cancer Institute and a Professor of Medicine at Harvard Medical School. [...]

  Dr. Robert A. Hiatt discusses the Institute of Medicine Report on Breast Cancer and the Environment: A Life-Course Approach, presented at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium. The report urges a life-course approach to studying breast cancer because new information suggests that women and girls might be more susceptible to some [...]

Dr. Julie R. Gralow discusses the SWOG SO226 where postmenopausal women with metastatic breast cancer given first-line treatment of fulvestrant (Faslodex) and anastrozole (Arimidix) have a better progression-free survival (PFS) than those given anastrozole alone. She also gives an update on bisphosphonates and osteonecrosis of the jaw at the 34th Annual CTRC-AACR San Antonio Breast [...]

  Dr. Clifford Hudis discusses what’s new with chemotherapy trials at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium. He reviews eight posters from the conference that explored various chemotherapy-related questions. Dr. Hudis is the Chief, Breast Cancer Medicine Service at Memorial Sloan Kettering Cancer Center and Professor of Medicine at Weill-Cornell Medical College [...]

  Dr. Clifford Hudis, through his discussion of the trial showing bevacizumab (Avastin) slows metastatic breast cancer, he highlights the important topic of the value of progression-free survival (PFS). This interview was conducted at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium. Dr. Hudis is the Chief, Breast Cancer Medicine Service at Memorial Sloan [...]

  Dr. Clifford Hudis discusses brain metastasis and a clinical trial ongoing at Memorial Sloan Kettering Cancer Center where researchers are testing chemotherapy penetration to the brain in a select group of trial-qualifying patients. This interview was conducted at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium. Dr. Hudis is the Chief, Breast Cancer [...]

  Dr. Hope Rugo discusses the chemotherapy agent, Eribulin and the results of a recent study focused on breast cancer patients with advanced disease. We also question if she thinks this is the end for chemotherapy agents in the treatment of breast cancer? This interview was conducted at the 34th Annual CTRC-AACR San Antonio Breast [...]

  Dr. Hope Rugo discusses the chemotherapy agent, Eribulin and the results of a recent study focused on breast cancer patients with advanced disease. We also question if she thinks this is the end for chemotherapy agents in the treatment of breast cancer? This interview was conducted at the 34th Annual CTRC-AACR San Antonio Breast [...]

  Dr. Ann Partridge discusses the differences, biologically, medically, and emotionally, in young women with breast cancer as compared to older women with breast cancer at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium. Dr. Partridge is the Clinical Director, Breast Oncology Center and Director, Program For Young Women With Breast Cancer at the [...]

  Dr. Martine Piccart, the current president of the European Society for Medical Oncology (ESMO), discusses the issues she would like to focus on during her two years as president. These include addressing the inequalities in cancer outcomes across Europe and improving them as well as how to cope with the shortage of medical oncologists [...]